These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38955494)

  • 1. Δ
    Mabou Tagne A; Fotio Y; Gupta K; Piomelli D
    J Pharmacol Exp Ther; 2024 Oct; 391(2):174-181. PubMed ID: 38955494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of DAGLβ as a therapeutic target for pain in sickle cell disease.
    Khasabova IA; Gable J; Johns M; Khasabov SG; Kalyuzhny AE; Golovko MY; Golovko SA; Kiven S; Gupta K; Seybold VS; Simone DA
    Haematologica; 2023 Mar; 108(3):859-869. PubMed ID: 35615929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cold exposure induces vaso-occlusion and pain in sickle mice that depend on complement activation.
    Ivy ZK; Belcher JD; Khasabova IA; Chen C; Juliette JP; Abdulla F; Ruan C; Allen K; Nguyen J; Rogness VM; Beckman JD; Khasabov SG; Gupta K; Taylor RP; Simone DA; Vercellotti GM
    Blood; 2023 Nov; 142(22):1918-1927. PubMed ID: 37774369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis constituent synergy in a mouse neuropathic pain model.
    Casey SL; Atwal N; Vaughan CW
    Pain; 2017 Dec; 158(12):2452-2460. PubMed ID: 28885457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Rankine-Mullings AE; Nevitt SJ
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD002202. PubMed ID: 36047926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyurea improves nitric oxide bioavailability in humanized sickle cell mice.
    Taylor CM; Kasztan M; Sedaka R; Molina PA; Dunaway LS; Pollock JS; Pollock DM
    Am J Physiol Regul Integr Comp Physiol; 2021 May; 320(5):R630-R640. PubMed ID: 33624556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gabapentin alleviates chronic spontaneous pain and acute hypoxia-related pain in a mouse model of sickle cell disease.
    Sadler KE; Langer SN; Menzel AD; Moehring F; Erb AN; Brandow AM; Stucky CL
    Br J Haematol; 2019 Oct; 187(2):246-260. PubMed ID: 31247672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sickle cell mice exhibit mechanical allodynia and enhanced responsiveness in light touch cutaneous mechanoreceptors.
    Garrison SR; Kramer AA; Gerges NZ; Hillery CA; Stucky CL
    Mol Pain; 2012 Sep; 8():62. PubMed ID: 22963123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ(9)-tetrahydrocannabinol in the rat.
    Craft RM; Kandasamy R; Davis SM
    Pain; 2013 Sep; 154(9):1709-1717. PubMed ID: 23707295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct antinociceptive and conditioned behavioral effects are produced by individual cannabinoids and a cannabis-derived mixture.
    Morris T; Cucinello-Ragland JA; Marks TJ; Prevost K; Glenn JF; Davenport GJ; Edwards S; Winsauer PJ
    Pharmacol Biochem Behav; 2024 Feb; 235():173692. PubMed ID: 38128766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse Models of Pain in Sickle Cell Disease.
    Sagi V; Song-Naba WL; Benson BA; Joshi SS; Gupta K
    Curr Protoc Neurosci; 2018 Oct; 85(1):e54. PubMed ID: 30265442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model.
    Casey SL; Mitchell VA; Sokolaj EE; Winters BL; Vaughan CW
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization of nociceptors by prostaglandin E
    Khasabova IA; Uhelski M; Khasabov SG; Gupta K; Seybold VS; Simone DA
    Blood; 2019 May; 133(18):1989-1998. PubMed ID: 30796025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease.
    Hillery CA; Kerstein PC; Vilceanu D; Barabas ME; Retherford D; Brandow AM; Wandersee NJ; Stucky CL
    Blood; 2011 Sep; 118(12):3376-83. PubMed ID: 21708890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization of C-fiber nociceptors in mice with sickle cell disease is decreased by local inhibition of anandamide hydrolysis.
    Uhelski ML; Gupta K; Simone DA
    Pain; 2017 Sep; 158(9):1711-1722. PubMed ID: 28570479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. THC and gabapentin interactions in a mouse neuropathic pain model.
    Atwal N; Casey SL; Mitchell VA; Vaughan CW
    Neuropharmacology; 2019 Jan; 144():115-121. PubMed ID: 30312630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute Δ
    Yadav-Samudrala BJ; Gorman BL; Dodson H; Ramineni S; Wallace ED; Peace MR; Poklis JL; Jiang W; Fitting S
    Brain Res; 2024 Jan; 1822():148638. PubMed ID: 37858856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single and combined effects of Δ
    King KM; Myers AM; Soroka-Monzo AJ; Tuma RF; Tallarida RJ; Walker EA; Ward SJ
    Br J Pharmacol; 2017 Sep; 174(17):2832-2841. PubMed ID: 28548225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Nevitt SJ; Jones AP; Howard J
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness.
    Cain DM; Vang D; Simone DA; Hebbel RP; Gupta K
    Br J Haematol; 2012 Feb; 156(4):535-44. PubMed ID: 22171826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.